Related references
Note: Only part of the references are listed.Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction
Robyn L. Poerschke et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer
Alberto J. Montero et al.
DRUGS (2011)
Selenodiglutathione uptake by the Saccharomyces cerevisiae vacuolar ATP-binding cassette transporter Ycf1p
Myriam Lazard et al.
FEBS JOURNAL (2011)
Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture
Carolin S. Hoefig et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Selenium and the Selenoprotein Thioredoxin Reductase in the Prevention, Treatment and Diagnostics of Cancer
Markus Selenius et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Thioredoxin and thioredoxin reductase: Current research with special reference to human disease
Arne Holmgren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Mammalian thioredoxin reductase 1: roles in redox homoeostasis and characterization of cellular targets
Anton A. Turanov et al.
BIOCHEMICAL JOURNAL (2010)
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase
Valentina Gandin et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Deficiency in the 15-kDa Selenoprotein Inhibits Tumorigenicity and Metastasis of Colon Cancer Cells
Robert Irons et al.
CANCER PREVENTION RESEARCH (2010)
Loss of Thioredoxin Reductase 1 Renders Tumors Highly Susceptible to Pharmacologic Glutathione Deprivation
Pankaj Kumar Mandal et al.
CANCER RESEARCH (2010)
Regulation and function of selenoproteins in human disease
Frederick P. Bellinger et al.
BIOCHEMICAL JOURNAL (2009)
Selenoproteins that function in cancer prevention and promotion
Dolph L. Hatfield et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) Reveals the Need for Better Understanding of Selenium Biology
Dolph L. Hatfield et al.
MOLECULAR INTERVENTIONS (2009)
Potent Activity of Indolequinones against Human Pancreatic Cancer: Identification of Thioredoxin Reductase as a Potential Target
Chao Yan et al.
MOLECULAR PHARMACOLOGY (2009)
Cytoprotective Nrf2 Pathway Is Induced In Chronically Txnrd 1-Deficient Hepatocytes
Elena S. Suvorova et al.
PLOS ONE (2009)
Extracellular thiol-assisted selenium uptake dependent on the xc- cystine transporter explains the cancer-specific cytotoxicity of selenite
Eric Olm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Selenium compounds and selenoproteins in cancer
Regina Brigelius-Flohe
CHEMISTRY & BIODIVERSITY (2008)
Thioredoxin Reductase-1 Negatively Regulates HIV-1 Transactivating Protein Tat-dependent Transcription in Human Macrophages
Parisa Kalantari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Targeting Thioredoxin Reductase 1 Reduction in Cancer Cells Inhibits Self-Sufficient Growth and DNA Replication
Min-Hyuk Yoo et al.
PLOS ONE (2007)
Effect of selenium on thioredoxin reductase activity in Txnrd1 or Txnrd2 hemizygous mice
Claudia Kiermayer et al.
BIOLOGICAL CHEMISTRY (2007)
Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells
Christine Marzano et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Oxidative stress and cancer: have we moved forward?
Barry Halliwell
BIOCHEMICAL JOURNAL (2007)
On the potential of thioredoxin reductase inhibitors for cancer therapy
Sabine Urig et al.
SEMINARS IN CANCER BIOLOGY (2006)
The thioredoxin system in cancer
Elias S. J. Arner et al.
SEMINARS IN CANCER BIOLOGY (2006)
Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress
Gustav Nilsonne et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model
Veda Diwadkar-Navsariwala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Thioredoxin reductase as a novel molecular target for cancer therapy
Phuongmai Nguyen et al.
CANCER LETTERS (2006)
Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells
MH Yoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells
B Husbeck et al.
PROSTATE (2006)
Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method
Irfan Rahman et al.
NATURE PROTOCOLS (2006)
Selenium in cancer prevention: a review of the evidence and mechanism of action
MP Rayman
PROCEEDINGS OF THE NUTRITION SOCIETY (2005)
Selenium and cancer chemoprevention:: Hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells
JX Lü et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells
AJ McEligot et al.
ANNUAL REVIEW OF NUTRITION (2005)
Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system
K Jönsson-Videsäter et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase
PJ Moos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity -: Effects on thioredoxin reductase and glutathione reductase
L Björkhem-Bergman et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Molecular mechanisms of cancer prevention by selenium compounds
J Fleming et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2001)
Structure-expression relationships of the 15-kDa selenoprotein gene - Possible role of the protein in cancer etiology
E Kumaraswamy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
